NIH-funded research R01 grant

Investigating a new target for stroke treatment

Official title: Ifi27l2a as a therapeutic target for stroke

Funded at University of Texas Hlth Sci Ctr Houston · NIH-11083116 · Data updated 2026-11-12

This study is looking at a protein called Ifi27l2a to see how it helps the brain respond to stroke, especially in older adults, with the hope that understanding it better could lead to new treatments that help people recover more effectively after a stroke.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startJuly 15, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$500,372
NIH project number5R01NS133324-03
Project IDNIH-11083116 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults, particularly those aged 65 and above, who have experienced a stroke.

Less likely to help

Patients who are younger than 65 or have not suffered a stroke may not benefit from this research.

What this research studies

This research focuses on understanding the role of a specific protein, Ifi27l2a, in the brain's immune response to stroke, particularly in older adults. The study aims to explore how this protein affects inflammation and recovery after a stroke by analyzing brain cells from both mice and humans. By using advanced techniques like single-cell transcriptomic analysis, the researchers hope to identify how manipulating this protein could improve outcomes for stroke patients. The ultimate goal is to develop targeted therapies that enhance recovery and reduce damage caused by stroke.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve recovery and outcomes for stroke patients, especially those over 65.

How similar studies have gone: Previous research has shown promise in targeting immune responses in stroke recovery, suggesting that this approach could be beneficial.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Kim, Gab Seok — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Kim, Gab Seok

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.